Join AMNet: An Addiction Medicine Practice-Based Research Network

AMNet is a network of office-based addiction medicine prescribers working to address the opioid epidemic and improve patient outcomes.

Your Participation Makes a Difference

A collaborative initiative from APA, American Society of Addiction Medicine (ASAM), Friends Research Institute (FRI), and the National Institute on Drug Abuse (NIDA), AMNet is seeking addiction medicine practices and their providers to participate in a practice-based research network. The network is focused on measuring and improving patient outcomes through the collection of data in PsychPRO - APA's CMS-Qualified Clinical Data Registry. AMNet will be able to help practices and thier providers drive quality improvement while creating a platform for future research studies.

APA members can join PsychPRO at no cost. Non-APA members who participate in AMNet will gain complimentary access to PsychPRO through July 31st, 2022. All AMNet members receive free CME clinical and research webinars to address the opioid epidemic. Contribute to this important effort focused on measuring and improving your patients' outcomes while building capacity to participate in future research if desired.

Complete this 5-minute survey to describe your practice and check your eligibility for AMNet.

Take Survey

About AMNet

Addiction medicine and addiction psychiatry office-based practices play an important role in responding to our nation's devastating opioid epidemic. Yet, little is known about the type of patients treated in these practices, the services they receive, and their clinical outcomes. Practices often have limited opportunities to organize their patient data to inform quality improvement efforts and are rarely invited to participate in clinical research. Although much is known about opioid treatment programs (OTP) and their patients, relatively little is known about providers and the patients they treat for substance use disorders in non-OTP outpatient programs, community health centers, and community mental health centers.

With funding support from the Office of the Assistant Secretary for Planning and Evaluation (ASPE) of the Department of Health and Human Services and the Patient-Centered Outcomes Research Trust Fund, AMNet was created as a joint initiative to address the nation's opioid epidemic and fill the gap in data by forging a practice-based research network.

AMNet participants will receive complimentary access to PsychPRO, APA's CMS-Qualified Clinical Data Registry for use in addiction medicine practices. PsychPRO has successfully integrated with over 15 electronic health record systems offering clinician- and patient-reported outcome measures, accessible via its clinician and patient portals, and an interactive dashboard to visualize patient-level information and facilitate data comparisons for quality improvement initiatives.

AMNet's addiction-related outcome measures in PsychPRO include:

  • Brief Addiction Monitor (BAM)
  • TAPS Tool
  • Treatment Effectiveness Assessment (TEA)
  • Short Opiate Withdrawal Scale (SOWS)
  • Clinicial Opiate Withdrawal Scale (COWS)
  • Visual Analogue Scale for Opioid Craving (VAS)
  • Patient Health Questionnaire (PHQ-2)
  • PROMIS Pain Interference

In addition, psychiatric measures available in PsychPRO include:

    • DSM-5 Cross-cutting measure
    • PHQ-9
    • GAD-7

Patients can complete these tools online, prior to their visit, or in the office on tablet computers provided for free to participating clinicians. Patient responses to measures will generate graphics, visualizing treatment progress over time.

PsychPRO's Interactive Dashboard Preview:

Click each image below for more dashboard views:

Who Should Participate in AMNet?

We are seeking practices and their providers including physicians, nurse practitioners, and physician assistants who prescribe any formulations of buprenorphine or naltrexone in a wide variety of outpatient settings, including:

      • Office-based Opioid Treatment Practices (OBOTs)
      • Intensive Outpatient Programs (IOPs)
      • Outpatient Programs (OPs)
      • Community Health Centers (CHCs, FQHCs)
      • Community Mental Health Centers (CMHCs)

Practices in health care and academic institutions, with or without EHRs, that regularly treat patients with opioid use and other substance use disorders are welcome. Practices can be located in urban, suburban, or rural areas. Telemedicine practices are eligible. We are currently not seeking providers in opioid treatment programs because more is known about their patient outcomes than in other settings.

Providers are eligible regardless of their membership status in APA, American Association of Addiction Psychiatry (AAAP), or ASAM.

Benefits of Joining AMNet

      • Free access to PsychPRO as described above
      • Real-time data to track patients' progress
      • Potential credit toward MOC Part IV Certification
      • Free CME webinars
      • $1,000 Honorarium
      • Tablet computer
      • Opportunity to participate in research
      • Support on the use of AMNet

Complete the Survey Today

If you would like to join AMNet or obtain more information, please complete the 5-minute survey using the link below.

Take Survey


Contact Us

If you have additional questions you are invited to contact us at

Contact Us

Funded by NIH/NIDA Grant Award: 3U01DA046910-02S2